<DOC>
	<DOC>NCT01014247</DOC>
	<brief_summary>The aim of this study is to investigate the effect of moxifloxacin on the QT interval in order to gain information on the validity of results that will be collected during another clinical study testing riociguat in patients with pulmonary arterial hypertension (PATENT-1 study).</brief_summary>
	<brief_title>Influence of Moxifloxacin on QTc Interval in Healthy Subjects for Positive Control Validation</brief_title>
	<detailed_description />
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
	<criteria>Healthy volunteers Age 1875 years Normal ECG Abnormal ECG Intolerance to fluorochinolones</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Moxifloxacin</keyword>
</DOC>